HIV Citation List: July 8, 2011- July 21, 2011

Pubmed citations

1. The New and Less Toxic Protease Inhibitor Saquinavir-NO Maintains anti-HIV-1 Properties In vitro Indistinguishable from Those of the Parental Compound Saquinavir. Canducci, F., E.R. Ceresola, D. Saita, Y. Al-Abed, G. Garotta, M. Clementi, and F. Nicoletti. Antiviral Research, 2011. [Epub ahead of print]; PMID[21763726].
[PubMed]. HIV_0708-072111.

2. Human-Phosphate-Binding-Protein Inhibits HIV-1 Gene Transcription and Replication. Cherrier, T., M. Elias, A. Jeudy, G. Gotthard, V. Le Douce, H. Hallay, P. Masson, A. Janossy, E. Candolfi, O. Rohr, E. Chabriere, and C. Schwartz. Virology Journal, 2011. 8(1): p. 352; PMID[21762475].
[PubMed]. HIV_0708-072111.

3. Synthesis, Activity, and Structural Analysis of Novel alpha-Hydroxytropolone Inhibitors of Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H. Chung, S., D.M. Himmel, J.K. Jiang, K. Wojtak, J.D. Bauman, J.W. Rausch, J.A. Wilson, J.A. Beutler, C.J. Thomas, E. Arnold, and S.F. Le Grice, Journal of Medicinal Chemistry. 2011. 54(13): p. 4462-4473; PMID[21568335].
[PubMed]. HIV_0708-072111.

4. 4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a Prototype to Develop Dual Inhibitors of HIV-1 Integration Process. De Luca, L., R. Gitto, F. Christ, S. Ferro, S. De Grazia, F. Morreale, Z. Debyser, and A. Chimirri. Antiviral Research, 2011. [Epub ahead of print]; PMID[21767569].
[PubMed]. HIV_0708-072111.

5. Structural Modifications of Quinolone-3-carboxylic acids with anti-HIV Activity. He, Q.Q., S.X. Gu, J. Liu, H.Q. Wu, X. Zhang, L.M. Yang, Y.T. Zheng, and F.E. Chen. Bioorganic & Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21763149].
[PubMed]. HIV_0708-072111.

6. Synthesis of the Anti-HIV Agent (-)-Hyperolactone C by Using Oxonium Ylide Formation-Rearrangement. Hodgson, D.M. and S. Man. Chemistry, 2011. [Epub ahead of print]; PMID[21766363].

[PubMed]. HIV_0708-072111.

7. Novel PI3K/Akt Inhibitors Screened by the Cytoprotective Function of Human Immunodeficiency Virus Type 1 Tat. Kim, Y., J.A. Hollenbaugh, D.H. Kim, and B. Kim. Plos One, 2011. 6(7): p. e21781; PMID[21765914].
[PubMed]. HIV_0708-072111.

8. Synthesis of Aminoglycoside-3'-Conjugates of 2'-O-Methyl Oligoribonucleotides and Their Invasion to a (19)F labeled HIV-1 TAR Model. Kiviniemi, A. and P. Virta, Bioconjugate. Chemistry, 2011. [Epub ahead of print]; PMID[21688836].
[PubMed]. HIV_0708-072111.

9. Antiviral Activity of Substituted Salicylanilides - A Review. Kratky, M. and J. Vinsova. Mini Reviews in Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21762100].
[PubMed]. HIV_0708-072111.

10. Targeting HIV Entry through Interaction with Envelope Glycoprotein 120 (gp120): Synthesis and Antiviral Evaluation of 1,3,5-Triazines with Aromatic Amino Acids. Lozano, V., L. Aguado, B. Hoorelbeke, M. Renders, M.J. Camarasa, D. Schols, J. Balzarini, A. San-Felix, and M.J. Perez-Perez. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21749165].
[PubMed]. HIV_0708-072111.

ISI Web of Knowledge citations:

11. Synthesis and Antimicrobial Activity of Some Novel 5-Alkyl-6-Substituted Uracils and Related Derivatives. Al-Turkistani, A.A., O.A. Al-Deeb, N.R. El-Brollosy, and A.A. El-Emam. Molecules. 2011. 16(6): p. 4764-4774; ISI[000292032700035].
[WOS]. HIV_0708-072111.

12. Partially Glycosylated Dendrimers Block MD-2 and Prevent TLR4-MD-2-LPS Complex Mediated Cytokine Responses. Barata, T.S., I. Teo, S. Brocchini, M. Zloh, and S. Shaunak. Plos Computational Biology, 2011. 7(6); ISI[000292381900035].
[WOS]. HIV_0708-072111.

13. Quantitative Structure-Activity Relationship Study of Phloroglucinol-terpene Adducts as Anti-leishmanial Agents. Bharate, S.B. and I.P. Singh. Bioorganic & Medicinal Chemistry Letters, 2011. 21(14): p. 4310-4315; ISI[000292186400042].
[WOS]. HIV_0708-072111.

14. Imidazo[1,2-a]pyridin-3-amines as Potential HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. Bode, M.L., D. Gravestock, S.S. Moleele, C.W. van der Westhuyzen, S.C. Pelly, P.A. Steenkamp, H.C. Hoppe, T. Khan, and L.A. Nkabinde. Bioorganic & Medicinal Chemistry, 2011. 19(14): p. 4227-4237; ISI[000292301200008].
[WOS]. HIV_0708-072111.

15. 3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L Mutant HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors: Docking-ased CoMFA and CoMSIA Analyses. Cichero, E., L. Buffa, and P. Fossa. Journal of Molecular Modeling, 2011. 17(7): p. 1537-1550; ISI[000292290600002].
[WOS]. HIV_0708-072111.

16. Synthesis of Cyclopropyl Peptidomimetics as Potential BACE and HIV Protease Inhibitors. Dunlap, N., N. Reddy, J. Taylor, and A.L. Pathiranage. Abstracts of Papers of the American Chemical Society, 2011. 241; ISI[000291982800893].
[WOS]. HIV_0708-072111.

17. Synergistic In vitro anti-HIV Type 1 Activity of Tenofovir with Carbohydrate-Binding Agents (CBAs). Ferir, G., K. Vermeire, D. Huskens, J. Balzarini, E.J.M. Van Damme, J.C. Kehr, E. Dittmann, M.D. Swanson, D.M. Markovitz, and D. Schols. Antiviral Research, 2011. 90(3): p. 200-204; ISI[000291912500014].

[WOS]. HIV_0708-072111.

18. Synthesis, Antibacterial and Potential anti-HIV Activity of Some Novel Imidazole Analogs. Ganguly, S., V.V. Vithlani, A.K. Kesharwani, R. Kuhu, L. Baskar, P. Mitramazumder, A. Sharon, and A. Dev. Acta Pharmaceutica, 2011. 61(2): p. 187-201; ISI[000291948800005].
[WOS]. HIV_0708-072111.

19. Synthesis and Enantioselective Hydrogenation of Seven-embered Cyclic Imines: Substituted Dibenzo[b,f][1,4]oxazepines. Gao, K., C.B. Yu, W. Li, Y.G. Zhou, and X.M. Zhang. Chemical Communications, 2011. 47(27): p. 7845-7847; ISI[000292113700085].
[WOS]. HIV_0708-072111.

20. Rational Engineering of Antiviral Lectins Targeting HIV. Green, D.F. Abstracts of Papers of the American Chemical Society, 2011. 241; ISI[000291982802364].
[WOS]. HIV_0708-072111.

21. Synthesis and Biological Evaluation of Naphthyl phenyl ethers (NPEs) as Novel Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors. Gu, S.X., X. Zhang, Q.Q. He, L.M. Yang, X.D. Ma, Y.T. Zheng, S.Q. Yang, and F.E. Chen. Bioorganic & Medicinal Chemistry, 2011. 19(14): p. 4220-4226; ISI[000292301200007].
[WOS]. HIV_0708-072111.

22. HIV Inhibitory Cyclic Depsipeptides from Marine Sponges: New Structural Features, Biological Activity Profiles, and Stereochemical Challenges. Gustafson, K.R. Biopolymers, 2011. 96(4): p. 422-422; ISI[000291763400054].
[WOS]. HIV_0708-072111.

23. Novel Macrocyclic Molecules as Entry Inhibitors of HIV-1. Joubran, S., J. Phanos, A. Swed, M. Kotler, A. Hofmann, and C. Gilon. Biopolymers, 2011. 96(4): p. 520-520; ISI[000291763400449].
[WOS]. HIV_0708-072111.

24. Discovery of BMS-663068, an HIV Attachment Inhibitor for the Treatment of HIV-1. Kadow, J.F., Y. Ueda, T.P. Connolly, T. Wang, C.P. Chen, K.S. Yeung, J. Bender, Z. Yang, J.L. Zhu, J. Mattiskella, A. Regueiro-Ren, Z.W. Yin, Z.X. Zhang, M. Farkas, X.J. Yang, H. Wong, D. Smith, K.S. Raghaven, Y. Pendri, A. Staab, N. Soundararajan, N. Meanwell, M. Zheng, D.D. Parker, S. Adams, H.T. Ho, G. Yamanaka, B. Nowicka-Sans, B. Eggers, B. McAuliffe, H. Fang, L. Fan, N. Zhou, Y.F. Gong, R.J. Colonno, P.F. Lin, J. Brown, D.M. Grasela, C. Chen, and R.E. Nettles. Abstracts of Papers of the American Chemical Society, 2011. 241; ISI[000291982806030].
[WOS]. HIV_0708-072111.

25. New Inhibitors for an Old Target: Pyrrolidines and Piperidines - Promising New Scaffolds to Block HIV Protease. Klee, N., K. Linde, I. Lindemann, A. Heine, G. Klebe, and W.E. Diederich. Abstracts of Papers of the American Chemical Society, 2011. 241; ISI[000291982806213].
[WOS]. HIV_0708-072111.

26. Understanding the Structure-Activity Relationship of Betulinic acid Derivatives as anti-HIV-1 Agents by Using 3D-QSAR and Docking. Lan, P., W.N. Chen, Z.J. Huang, P.H. Sun, and W.M. Chen. Journal of Molecular Modeling, 2011. 17(7): p. 1643-1659; ISI[000292290600012].
[WOS]. HIV_0708-072111.

27. Peptide Based Inhibitor of HIV1 Entry. Luna, A., J.T. Ngo, and D.A. Tirrell. Abstracts of Papers of the American Chemical Society, 2011. 241; ISI[000291982800375].
[WOS]. HIV_0708-072111.

28. Development of Modified Nucleosides that have Supremely High anti-HIV activity and Low Toxicity and Prevent the Emergence of Resistant HIV Mutants. Ohrui, H. Proceedings of the Japan Academy Series B-Physical and Biological Sciences, 2011. 87(3): p. 53-65; ISI[000291958200002].
[WOS]. HIV_0708-072111.

29. Design, Synthesis and Biological Evaluation of 2 '-Deoxy-2 ',2 '-difluoro-5-halouridine phosphoramidate ProTides. Quintiliani, M., L. Persoons, N. Solaroli, A. Karlsson, G. Andrei, R. Snoeck, J. Balzarini, and C. McGuigan. Bioorganic & Medicinal Chemistry, 2011. 19(14): p. 4338-4345; ISI[000292301200019].

[WOS]. HIV_0708-072111.

30. Synthesis and Biological Activities of Novel s-Triazine Bridged Dinucleoside Analogs. Shen, F.J., X.L. Li, X.Y. Zhang, B. Zhanbin, Q.M. Yin, H. Chen, and J.C. Zhang. Chinese Journal of Chemistry, 2011. 29(6): p. 1205-1210; ISI[000292215300021].
[WOS]. HIV_0708-072111.

31. Virucidal Activity of the Dendrimer Microbicide SPL7013 against HIV-1. Telwatte, S., K. Moore, A. Johnson, D. Tyssen, J. Sterjovski, M. Aldunate, P.R. Gorry, P.A. Ramsland, G.R. Lewis, J.R.A. Paull, S. Sonza, and G. Tachedjian. Antiviral Research, 2011. 90(3): p. 195-199; ISI[000291912500013].

[WOS]. HIV_0708-072111.

32. Synthesis and Biological Evaluation of Novel 5-Alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3 H)-ones as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Zhang, J., P. Zhan, J.D. Wu, Z.Y. Li, Y. Jiang, W.Y. Ge, C. Pannecouque, E. De Clercq, and X.Y. Liu. Bioorganic & Medicinal Chemistry, 2011. 19(14): p. 4366-4376; ISI[000292301200022].
[WOS]. HIV_0708-072111.